Skip to main content
. 2021 Mar 15;14:1153–1166. doi: 10.2147/DMSO.S288313

Table 6.

Antihyperglycemic Activity of Isolates in STZ-Induced Diabetic Mice

Treatment Group Fasting Blood Glucose Level mg/dl
Fbg0 Fbg7 Fbg14 Fbg21 %Redn
(normal) 2% DMSO 122.17 ± 8.09 129.50 ± 6.48 123.33 ± 4.43 119.00 ± 2.89 2.46
(diabetic) 2% DMSO 314.00 ± 19.73 329.17 ± 16.2 336.33 ± 16.88 352.83 ± 16.19 − 12.37
200 mg/kg Ia 312.00 ± 17.28 299.17 ± 16.51 290.33 ± 15.55 290.17 ± 17.28 6.99
400 mg/kg Ia 299.83 ± 12.99 280.33 ± 14.31 276.17 ± 17.22 261.17 ± 16.33** 12.89
200 mg/kg Ib 355.83 ± 26.88 305.83 ± 24.41 291.00 ± 22.74 259.67 ± 19.88** 27.02
400 mg/kg Ib 318.50 ± 38.97 283.17 ± 25.29 242.50 ± 12.95** 203.5 ± 13.19*** 36.1
200 mg/kg Ic 290.50 ± 16.69 275.33 ± 16.94 267.67 ± 16.00 283.17 ± 19.05 2.5
400 mg/kg Ic 339.67 ± 16.31 316.17 ± 22.97 291.33 ± 24.10 285.17 ± 25.21 16.04
2 mg/kg GA 325.83 ± 34.87 234.67 ± 13.79* 174.30 ± 5.78*** 135.83 ± 8.01*** 58.3

Notes: Data are expressed as Mean ± Standard Error of Mean (SEM); n=6; Where *significant values at p<0.05 compared with group II; ** Significant values at p<0.01 compared with group II; *** Significant values at p<0.001 compared with group II.

Abbreviations: DMSO, dimethyl sulfoxide; GA, glibenclamide; % redn, percent of reduction; Ia, isolate a; Ib, isolate b; Ic, isolate c.